Strategic Diagnostics has sold its RapidChek Listeria and RapidChek Select for Salmonella test platforms to three major food processors with a combined annual value in excess of $800,000 per year
"Major food processors continue to embrace our methodologies as the preferred testing process to ensure the ongoing safety of their products and maintain consumer confidence," commented Matt Knight, president and CEO of Strategic Diagnostics.
"Within this mature market, we continue to capture accounts with high-volume testing needs, demonstrating our ability to take market share from well established competitive methods and validating our technology.
"Our success is due to our ability to clearly demonstrate both the technical performance of our methods, and ultimately their superior cost in use".
With the introduction of RapidChek Select for Salmonella in late August of 2006, SDI was, for the first time, able to offer state-of-the-art tests for the detection of all three regulated food pathogens in the USA.
In addition to the superior performance of each of the three methods, the company also sees its ability to offer all three tests, on the same platform, as contributing to broader industry adoption going forward.
The company believes it is well-positioned to increase its market share within the salmonella testing market, an industry currently estimated at $75 million annually.
